Cervical cancer control in HIV-infected women: Past, present and future.
Identifieur interne : 004568 ( Ncbi/Merge ); précédent : 004567; suivant : 004569Cervical cancer control in HIV-infected women: Past, present and future.
Auteurs : Rahel G. Ghebre [États-Unis] ; Surbhi Grover [États-Unis] ; Melody J. Xu [États-Unis] ; Linus T. Chuang [États-Unis] ; Hannah Simonds [Afrique du Sud]Source :
- Gynecologic oncology reports [ 2352-5789 ] ; 2017.
Abstract
Since the initial recognition of acquired immunodeficiency syndrome (AIDS) in 1981, an increased burden of cervical cancer was identified among human immunodeficiency virus (HIV)-positive women. Introduction of antiretroviral therapy (ART) decreased risks of opportunistic infections and improved overall survival. HIV-infected women are living longer. Introduction of the human papillomavirus (HPV) vaccine, cervical cancer screening and early diagnosis provide opportunities to reduce cervical cancer associated mortality. In line with 2030 Sustainable Development Goals to reduce mortality from non-communicable diseases, increased efforts need to focus on high burden countries within sub-Saharan Africa (SSA). Despite limitations of resources in SSA, opportunities exist to improve cancer control. This article reviews advancements in cervical cancer control in HIV-positive women.
DOI: 10.1016/j.gore.2017.07.009
PubMed: 28819634
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000751
- to stream PubMed, to step Curation: 000751
- to stream PubMed, to step Checkpoint: 000751
Links to Exploration step
pubmed:28819634Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cervical cancer control in HIV-infected women: Past, present and future.</title><author><name sortKey="Ghebre, Rahel G" sort="Ghebre, Rahel G" uniqKey="Ghebre R" first="Rahel G" last="Ghebre">Rahel G. Ghebre</name><affiliation wicri:level="2"><nlm:affiliation>University of Minnesota Medical School, Minneapolis, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of Minnesota Medical School, Minneapolis, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Grover, Surbhi" sort="Grover, Surbhi" uniqKey="Grover S" first="Surbhi" last="Grover">Surbhi Grover</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Xu, Melody J" sort="Xu, Melody J" uniqKey="Xu M" first="Melody J" last="Xu">Melody J. Xu</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, University of California San Francisco, San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Chuang, Linus T" sort="Chuang, Linus T" uniqKey="Chuang L" first="Linus T" last="Chuang">Linus T. Chuang</name><affiliation wicri:level="2"><nlm:affiliation>Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Simonds, Hannah" sort="Simonds, Hannah" uniqKey="Simonds H" first="Hannah" last="Simonds">Hannah Simonds</name><affiliation wicri:level="1"><nlm:affiliation>Division of Radiation Oncology, Tygerberg Hospital/University of Stellenbosch, Stellenbosch, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Division of Radiation Oncology, Tygerberg Hospital/University of Stellenbosch, Stellenbosch</wicri:regionArea><wicri:noRegion>Stellenbosch</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28819634</idno><idno type="pmid">28819634</idno><idno type="doi">10.1016/j.gore.2017.07.009</idno><idno type="wicri:Area/PubMed/Corpus">000751</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000751</idno><idno type="wicri:Area/PubMed/Curation">000751</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000751</idno><idno type="wicri:Area/PubMed/Checkpoint">000751</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000751</idno><idno type="wicri:Area/Ncbi/Merge">004568</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cervical cancer control in HIV-infected women: Past, present and future.</title><author><name sortKey="Ghebre, Rahel G" sort="Ghebre, Rahel G" uniqKey="Ghebre R" first="Rahel G" last="Ghebre">Rahel G. Ghebre</name><affiliation wicri:level="2"><nlm:affiliation>University of Minnesota Medical School, Minneapolis, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of Minnesota Medical School, Minneapolis, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Grover, Surbhi" sort="Grover, Surbhi" uniqKey="Grover S" first="Surbhi" last="Grover">Surbhi Grover</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Xu, Melody J" sort="Xu, Melody J" uniqKey="Xu M" first="Melody J" last="Xu">Melody J. Xu</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, University of California San Francisco, San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Chuang, Linus T" sort="Chuang, Linus T" uniqKey="Chuang L" first="Linus T" last="Chuang">Linus T. Chuang</name><affiliation wicri:level="2"><nlm:affiliation>Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Simonds, Hannah" sort="Simonds, Hannah" uniqKey="Simonds H" first="Hannah" last="Simonds">Hannah Simonds</name><affiliation wicri:level="1"><nlm:affiliation>Division of Radiation Oncology, Tygerberg Hospital/University of Stellenbosch, Stellenbosch, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Division of Radiation Oncology, Tygerberg Hospital/University of Stellenbosch, Stellenbosch</wicri:regionArea><wicri:noRegion>Stellenbosch</wicri:noRegion></affiliation></author></analytic><series><title level="j">Gynecologic oncology reports</title><idno type="ISSN">2352-5789</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Since the initial recognition of acquired immunodeficiency syndrome (AIDS) in 1981, an increased burden of cervical cancer was identified among human immunodeficiency virus (HIV)-positive women. Introduction of antiretroviral therapy (ART) decreased risks of opportunistic infections and improved overall survival. HIV-infected women are living longer. Introduction of the human papillomavirus (HPV) vaccine, cervical cancer screening and early diagnosis provide opportunities to reduce cervical cancer associated mortality. In line with 2030 Sustainable Development Goals to reduce mortality from non-communicable diseases, increased efforts need to focus on high burden countries within sub-Saharan Africa (SSA). Despite limitations of resources in SSA, opportunities exist to improve cancer control. This article reviews advancements in cervical cancer control in HIV-positive women.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28819634</PMID><DateCreated><Year>2017</Year><Month>08</Month><Day>18</Day></DateCreated><DateRevised><Year>2017</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2352-5789</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><PubDate><Year>2017</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Gynecologic oncology reports</Title><ISOAbbreviation>Gynecol Oncol Rep</ISOAbbreviation></Journal><ArticleTitle>Cervical cancer control in HIV-infected women: Past, present and future.</ArticleTitle><Pagination><MedlinePgn>101-108</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gore.2017.07.009</ELocationID><Abstract><AbstractText>Since the initial recognition of acquired immunodeficiency syndrome (AIDS) in 1981, an increased burden of cervical cancer was identified among human immunodeficiency virus (HIV)-positive women. Introduction of antiretroviral therapy (ART) decreased risks of opportunistic infections and improved overall survival. HIV-infected women are living longer. Introduction of the human papillomavirus (HPV) vaccine, cervical cancer screening and early diagnosis provide opportunities to reduce cervical cancer associated mortality. In line with 2030 Sustainable Development Goals to reduce mortality from non-communicable diseases, increased efforts need to focus on high burden countries within sub-Saharan Africa (SSA). Despite limitations of resources in SSA, opportunities exist to improve cancer control. This article reviews advancements in cervical cancer control in HIV-positive women.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghebre</LastName><ForeName>Rahel G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Resources for Health, Rwanda.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Yale University, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grover</LastName><ForeName>Surbhi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Melody J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuang</LastName><ForeName>Linus T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonds</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Radiation Oncology, Tygerberg Hospital/University of Stellenbosch, Stellenbosch, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Gynecol Oncol Rep</MedlineTA><NlmUniqueID>101652231</NlmUniqueID><ISSNLinking>2352-5789</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Int J Gynecol Cancer. 2015 Jun;25(5):884-90</RefSource><PMID Version="1">25853380</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2015 Feb 19;372(8):711-23</RefSource><PMID Version="1">25693011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2004 Mar 1;22(5):872-80</RefSource><PMID Version="1">14990643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2006 Aug 1;20(12):1645-54</RefSource><PMID Version="1">16868446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2012 Jun 1;118(11):2971-9</RefSource><PMID Version="1">22072021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2010 Oct;55(2):197-204</RefSource><PMID Version="1">20574412</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1996 Apr 18;334(16):1011-7</RefSource><PMID Version="1">8598838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 1986 Jun 20;255(23):3255-9</RefSource><PMID Version="1">3012131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2005 Jun;5(6):374-82</RefSource><PMID Version="1">15919623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Surg Oncol. 2016 Aug 05;14 (1):208</RefSource><PMID Version="1">27495294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Dis Obstet Gynecol. 2012;2012:610876</RefSource><PMID Version="1">22675242</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Oncol. 2015 Nov 03;5:239</RefSource><PMID Version="1">26579491</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2010 Apr 15;115(15):3017-24</RefSource><PMID Version="1">20130244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MMWR Morb Mortal Wkly Rep. 1990 Nov 30;39(47):846-9</RefSource><PMID Version="1">2172758</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2005 Oct 1;41(7):1045-8</RefSource><PMID Version="1">16142673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Oncol Pract. 2016 Jul;12(7):693-6</RefSource><PMID Version="1">27328791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2012 Aug;23(8):2006-15</RefSource><PMID Version="1">22345118</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Apr 17;10(4):e0122169</RefSource><PMID Version="1">25885821</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Obstet Gynaecol. 2008 Aug;28(6):638-41</RefSource><PMID Version="1">19003664</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Oncol. 2015 Jan 22;4:380</RefSource><PMID Version="1">25657930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Low Genit Tract Dis. 2016 Jul;20(3):218-23</RefSource><PMID Version="1">27030883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30</RefSource><PMID Version="1">11078759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2014 Jul 1;59(1):127-35</RefSource><PMID Version="1">24723284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Surg Oncol. 2013 Feb;39(2):115-24</RefSource><PMID Version="1">23084091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(1):e53494</RefSource><PMID Version="1">23326441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2012 Oct;206(8):1309-18</RefSource><PMID Version="1">22859825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1998 Mar 26;338(13):853-60</RefSource><PMID Version="1">9516219</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):596-604</RefSource><PMID Version="1">24469258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):432-42</RefSource><PMID Version="1">11511819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2014 May;58(9):1308-11</RefSource><PMID Version="1">24585567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2009 Feb 1;115(3):524-30</RefSource><PMID Version="1">19127538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2003 Jul 7;89(1):101-5</RefSource><PMID Version="1">12838308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 1980 Feb;9(1):90-8</RefSource><PMID Version="1">7353805</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2009 Aug 19;101(16):1120-30</RefSource><PMID Version="1">19648510</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Compr Canc Netw. 2015 Apr;13(4):395-404; quiz 404</RefSource><PMID Version="1">25870376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2010 Oct 23;24(16):2553-61</RefSource><PMID Version="1">20706107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2015 Mar;65(2):87-108</RefSource><PMID Version="1">25651787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2007 Jul 7;370(9581):59-67</RefSource><PMID Version="1">17617273</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1999 Apr 15;340(15):1144-53</RefSource><PMID Version="1">10202165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Radiat Oncol. 2017 Apr;27(2):136-142</RefSource><PMID Version="1">28325239</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1981 Dec 10;305(24):1465-7</RefSource><PMID Version="1">6272112</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2002 Mar 8;16(4):531-6</RefSource><PMID Version="1">11872995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19</RefSource><PMID Version="1">1361652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4</RefSource><PMID Version="1">19357635</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2016 Nov 15;165(10 ):749-750</RefSource><PMID Version="1">27842400</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MMWR Morb Mortal Wkly Rep. 1983 Jan 7;31(52):697-8</RefSource><PMID Version="1">6402650</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet HIV. 2016 Aug;3(8):e361-87</RefSource><PMID Version="1">27470028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 1990 Sep;38(3):377-82</RefSource><PMID Version="1">2227552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Jul 1;25(19):2804-10</RefSource><PMID Version="1">17502627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1997 May 15;89(10):3700-7</RefSource><PMID Version="1">9160675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Obstet Gynecol. 1989 Feb;160(2):352-3</RefSource><PMID Version="1">2537013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol Community Health. 2016 Jan;70(1):17-24</RefSource><PMID Version="1">26202254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2004 Jul 1;190(1):37-45</RefSource><PMID Version="1">15195241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2009 Jul 25;374(9686):301-14</RefSource><PMID Version="1">19586656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2007 May 10;356(19):1915-27</RefSource><PMID Version="1">17494925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2017 Feb 20;31(4):523-531</RefSource><PMID Version="1">28060014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2014 Aug 15;135(4):896-904</RefSource><PMID Version="1">24391021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Agent Cancer. 2014 Dec 08;9:40</RefSource><PMID Version="1">25926864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood Rev. 2002 Mar;16(1):73-6</RefSource><PMID Version="1">11914001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2013 Sep;57(5):735-44</RefSource><PMID Version="1">23667266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiology. 2006 Jan;238(1):272-9</RefSource><PMID Version="1">16304090</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cervical cancer</Keyword><Keyword MajorTopicYN="N">Cervical cancer screening</Keyword><Keyword MajorTopicYN="N">Chemoradiation therapy</Keyword><Keyword MajorTopicYN="N">Human immunodeficiency virus (HIV)</Keyword><Keyword MajorTopicYN="N">Limited resource setting</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>07</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28819634</ArticleId><ArticleId IdType="doi">10.1016/j.gore.2017.07.009</ArticleId><ArticleId IdType="pii">S2352-5789(17)30081-4</ArticleId><ArticleId IdType="pmc">PMC5548335</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Afrique du Sud</li><li>États-Unis</li></country><region><li>Californie</li><li>Minnesota</li><li>Pennsylvanie</li><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="Minnesota"><name sortKey="Ghebre, Rahel G" sort="Ghebre, Rahel G" uniqKey="Ghebre R" first="Rahel G" last="Ghebre">Rahel G. Ghebre</name></region><name sortKey="Chuang, Linus T" sort="Chuang, Linus T" uniqKey="Chuang L" first="Linus T" last="Chuang">Linus T. Chuang</name><name sortKey="Grover, Surbhi" sort="Grover, Surbhi" uniqKey="Grover S" first="Surbhi" last="Grover">Surbhi Grover</name><name sortKey="Xu, Melody J" sort="Xu, Melody J" uniqKey="Xu M" first="Melody J" last="Xu">Melody J. Xu</name></country><country name="Afrique du Sud"><noRegion><name sortKey="Simonds, Hannah" sort="Simonds, Hannah" uniqKey="Simonds H" first="Hannah" last="Simonds">Hannah Simonds</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004568 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004568 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:28819634
|texte= Cervical cancer control in HIV-infected women: Past, present and future.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28819634" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |